Tian Ma

435 total citations
20 papers, 344 citations indexed

About

Tian Ma is a scholar working on Immunology, Molecular Biology and Dermatology. According to data from OpenAlex, Tian Ma has authored 20 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 7 papers in Molecular Biology and 6 papers in Dermatology. Recurrent topics in Tian Ma's work include Psoriasis: Treatment and Pathogenesis (9 papers), Dermatology and Skin Diseases (6 papers) and Retinoids in leukemia and cellular processes (4 papers). Tian Ma is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (9 papers), Dermatology and Skin Diseases (6 papers) and Retinoids in leukemia and cellular processes (4 papers). Tian Ma collaborates with scholars based in China, United States and United Kingdom. Tian Ma's co-authors include Bin Li, Xin Li, Xiaoying Sun, Ethan Dmitrovsky, Sarah J. Freemantle, David Sekula, Yongli Guo, Fabrizio Galimberti, Qi Zheng and Wenbin Xu and has published in prestigious journals such as Cancer Research, Journal of Virology and Journal of Ethnopharmacology.

In The Last Decade

Tian Ma

20 papers receiving 344 citations

Peers

Tian Ma
Comparison fields: 5 of 62
  • Immunology 187
  • Molecular Biology 157
  • Oncology 64
  • Dermatology 59
  • Cancer Research 34
Jie Wan Kim South Korea
Meng Xing China
Emily A. Smith United States
Cheol‐Jung Lee South Korea
Hye‐Rim Park South Korea
Gwenda F. Ligon United States
Jiao Qu China
Xianghui Ma China
Guanqun Xie China
Deborah Alpert United States
Jie Wan Kim South Korea View profile →
Citations per field, relative to Tian Ma
Tian Ma · 1×
Citations per year, relative to Tian Ma
Tian Ma · 1×

Countries citing papers authored by Tian Ma

Since Specialization
Citations

This map shows the geographic impact of Tian Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian Ma more than expected).

Fields of papers citing papers by Tian Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tian Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian Ma. The network helps show where Tian Ma may publish in the future.

Co-authorship network of co-authors of Tian Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Tian Ma. A scholar is included among the top collaborators of Tian Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tian Ma. Tian Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 1
3 13
4 5
5 30
6 3
7 8
8 29
9 7
10 10
11 35
12 22
13 10
14
Diosgenin inhibits IL-1β-induced expression of inflammatory mediators in human osteoarthritis chondrocytes.
30
15 13
16 7
17 2
18 30
19 36
20 52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026